Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

NCT00745407 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2008-09-03

No results posted yet for this study

Summary

Fenofibrate increases adiponectin levels, but reduces leptin levels

Conditions

  • Hypertriglyceridemia

Interventions

DRUG

fenofibrate

Sponsors & Collaborators

  • Gachon University Gil Medical Center

    lead OTHER

Study Design

Purpose
TREATMENT
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2008-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00745407 on ClinicalTrials.gov